79 related articles for article (PubMed ID: 2365110)
1. [Therapeutic use of splenopentin (DA SP-5) in patients with psoriasis arthropathica].
Greiner J; Miehe M; Weber H; Stoimenov A; Sönnichsen N; Diezel W
Dermatol Monatsschr; 1990; 176(2-3):157-62. PubMed ID: 2365110
[TBL] [Abstract][Full Text] [Related]
2. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
[TBL] [Abstract][Full Text] [Related]
3. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
[TBL] [Abstract][Full Text] [Related]
4. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee].
Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U
Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320
[TBL] [Abstract][Full Text] [Related]
5. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
[TBL] [Abstract][Full Text] [Related]
6. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
[TBL] [Abstract][Full Text] [Related]
7. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
[TBL] [Abstract][Full Text] [Related]
8. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies.
Grob PJ; Binswanger U; Blumberg A; Gloor HJ; Hany A; Herwig W; Iselin H; Zàruba K; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():107-15. PubMed ID: 3898281
[TBL] [Abstract][Full Text] [Related]
9. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
10. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
11. [Splenin phonophoresis in the complex treatment of patients with vasomotor and allergic rhinitis].
Potapova RG; Ishukova AK; Kosiakova EI
Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):53-4. PubMed ID: 6730393
[No Abstract] [Full Text] [Related]
12. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
[TBL] [Abstract][Full Text] [Related]
13. [Thymopentin in the treatment of recurrent condylomata acuminata].
Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
[TBL] [Abstract][Full Text] [Related]
14. Splenopentin--influence on antibody formation in immunosuppressed animals and on phagocytic capability of human granulocytes.
Diezel W; Eckert R; Müller GM; Forner K; Sönnichsen N
Arch Geschwulstforsch; 1989; 59(3):161-4. PubMed ID: 2667491
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
[TBL] [Abstract][Full Text] [Related]
16. [Levamisole and splenin in combined therapy of patients with bronchiectasis].
Sokhin AA; Monogarova NE; Zeligman VS; Chernykh SN; Radugina GS
Klin Med (Mosk); 1989 Sep; 67(9):38-41. PubMed ID: 2586038
[TBL] [Abstract][Full Text] [Related]
17. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
[TBL] [Abstract][Full Text] [Related]
18. [Psoriasis and psoriatic arthritis--is climate therapy a treatment or a leisure activity?].
Mørk C; Ozek M; Wahl AK
Tidsskr Nor Laegeforen; 2004 Jan; 124(1):60-2. PubMed ID: 14716397
[TBL] [Abstract][Full Text] [Related]
19. Splenopentin-induced reconstitution of the immune response after total body irradiation: optimization of treatment regime.
Eckert R; Schmidt R; Volk HD; Diezel W; Sönnichsen N; von Baehr R
Exp Clin Endocrinol; 1989 Sep; 94(1-2):223-5. PubMed ID: 2689192
[TBL] [Abstract][Full Text] [Related]
20. Measurement of disease activity in psoriatic arthritis. Extended report.
Ujfalussy I; Koó E
Z Rheumatol; 2003 Feb; 62(1):60-5. PubMed ID: 12624805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
